İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

68 F
San Diego
Sunday, May 19, 2024
-Advertisement-

ViaCyte Raises $5.4 Million in Private Financing

ViaCyte Inc. has announced it has raised $5.4 million in private financing to pursue the clinical development of its artificial pancreas, which could treat type 1 diabetes.

The San Diego-based company said it completed a private equity financing through the sale of Series C-1 preferred stock. The first closing of the Series C-1 financing occurred in July 2013. This additional investment brings the total to $16.5 million. The company said a nonprofit corporation and several individuals participated in the offering.

ViaCyte also announced the submission of an Investigational New Drug application and a Medical Device Master File to the U.S. Food and Drug Administration seeking permission to begin clinical evaluation of the product candidate.

ViaCyte is a private regenerative medicine company focused on developing cell therapy for the treatment of diabetes.

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-